Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 18/20 | 0.59 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19498887 | 0.98 | IL23R (0.59) | IL23RKISS1RNPBWR1 | |
| SCHEMBL19498884 | 0.93 | KISS1R (0.62) | IL23RKISS1RNPBWR1 | |
| SCHEMBL30802584 | 0.91 | KISS1R (0.63) | KISS1R | |
| SCHEMBL30450426 | 0.89 | KISS1R (0.63) | IL23RKISS1R | |
| SCHEMBL29595776 | 0.88 | KISS1R (0.62) | KISS1R | |
| SCHEMBL29595208 | 0.88 | KISS1R (0.62) | KISS1R | |
| SCHEMBL23839903 | 0.87 | KISS1R (0.59) | KISS1R | |
| SCHEMBL15354488 | 0.87 | IL23R (0.65) | IL23RKISS1R | |
| SCHEMBL20376152 | 0.87 | KISS1R (0.60) | IL23RKISS1R | |
| SCHEMBL20376297 | 0.87 | KISS1R (0.60) | IL23RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11167277-B2 | Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2021-11-09 | — | — | US | disclosed |
| US-20200398262-A1 | CU(I)-CATALYZED AZIDE-ALKYNE CYCLOADDITIONS (CUAAC) LIGANDS AND METHODS FOR CARRYING OUT CU(I)-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTIONS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200398262-A1 | CU(I)-CATALYZED AZIDE-ALKYNE CYCLOADDITIONS (CUAAC) LIGANDS AND METHODS FOR CARRYING OUT CU(I)-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTIONS | RNGTT, AOC2, CTRC | IL23R 3027/4885KISS1R 1405/4885NPBWR1 3205/4885 |
| US-11167277-B2 | Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions | RNGTT, AOC2, CTRC | IL23R 3027/4885KISS1R 1405/4885NPBWR1 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.